Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Tranquart, F; Saliba, E; Barantin, L; Lanneau, M; Simmer, L; Guilloteau, D; Baulieu, JL
   D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT
   CLINICAL NUCLEAR MEDICINE
   
   F. Tranquart et al., "D2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT", CLIN NUCL M, 26(1), 2001, pp. 36-40
2. Lavigne, GJ; Soucy, JP; Lobbezoo, F; Manzini, C; Blanchet, PJ; Montplaisir, JY
   Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism
   CLINICAL NEUROPHARMACOLOGY
   
   G.J. Lavigne et al., "Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism", CLIN NEUROP, 24(3), 2001, pp. 145-149
3. Videbaek, C; Toska, K; Friberg, L; Holm, S; Angelo, HR; Knudsen, GM
   In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by[I-123]IBZM and single photon emission computed tomography
   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
   
   C. Videbaek et al., "In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by[I-123]IBZM and single photon emission computed tomography", J CEREBR B, 21(1), 2001, pp. 92-97
4. Zea-Ponce, Y; Laruelle, M
   Synthesis of [I-123]IBZM: A reliable procedure for routine clinical studies
   NUCLEAR MEDICINE AND BIOLOGY
   
   Y. Zea-Ponce e M. Laruelle, "Synthesis of [I-123]IBZM: A reliable procedure for routine clinical studies", NUCL MED BI, 26(6), 1999, pp. 661-665
5. de Herder, WW; Reijs, AEM; de Swart, J; Kaandorp, Y; Lamberts, SWJ; Krenning, EP; Kwekkeboom, DJ
   Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D-2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas
   EUROPEAN JOURNAL OF NUCLEAR MEDICINE
   
   W.W. de Herder et al., "Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D-2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas", EUR J NUCL, 26(1), 1999, pp. 46-50
6. Baulieu, JL; Ribeiro, MJ; Levilion-Prunier, C; Tranquart, F; Chartier, JR; Guilloteau, D; Cottier, JP; Besnard, JC; Pourcelot, L; Autret, A
   Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using I-123-iodolisuride SPET
   NUCLEAR MEDICINE COMMUNICATIONS
   
   J.L. Baulieu et al., "Effects of the method of drawing regions of interest on the differential diagnosis of extrapyramidal syndromes using I-123-iodolisuride SPET", NUCL MED C, 20(1), 1999, pp. 77-84
7. WANG TST; MALASPINA D; VANHEERTUM RL
   A SIMPLE METHOD OF PREPARATION FOR [I-I23]-(S)-(-)-IBZM
   Applied radiation and isotopes
   
   T.S.T. Wang et al., "A SIMPLE METHOD OF PREPARATION FOR [I-I23]-(S)-(-)-IBZM", Applied radiation and isotopes, 49(4), 1998, pp. 369-372
8. HEINZ A; KNABLE MB; COPPOLA R; GOREY JG; JONES DW; LEE KS; WEINBERGER DR
   PSYCHOMOTOR SLOWING, NEGATIVE SYMPTOMS AND DOPAMINE-RECEPTOR AVAILABILITY - AN IBZM SPECT STUDY IN NEUROLEPTIC-TREATED AND DRUG-FREE SCHIZOPHRENIC-PATIENTS
   Schizophrenia research
   
   A. Heinz et al., "PSYCHOMOTOR SLOWING, NEGATIVE SYMPTOMS AND DOPAMINE-RECEPTOR AVAILABILITY - AN IBZM SPECT STUDY IN NEUROLEPTIC-TREATED AND DRUG-FREE SCHIZOPHRENIC-PATIENTS", Schizophrenia research, 31(1), 1998, pp. 19-26
9. HIERHOLZER J; CORDES M; VENZ S; SCHELOSKY L; HARISCH C; RICHTER W; KESKE U; HOSTEN N; MAURER J; POEWE W; FELIX R
   LOSS OF DOPAMINE-D2 RECEPTOR-BINDING SITES IN PARKINSONIAN PLUS SYNDROMES
   The Journal of nuclear medicine
   
   J. Hierholzer et al., "LOSS OF DOPAMINE-D2 RECEPTOR-BINDING SITES IN PARKINSONIAN PLUS SYNDROMES", The Journal of nuclear medicine, 39(6), 1998, pp. 954-960
10. KAPUCU LO; KOC E; GUCUYENER K; ZENCIROGLU A; ATALAY Y; UNLU M; VANROYEN E
    D-2 RECEPTOR IMAGING WITH IODINE-123-IODOBENZAMIDE BRAIN SPECT IN INFANTS WITH HYPOXIC-ISCHEMIC BRAIN INJURY
    The Journal of nuclear medicine
    
    L.O. Kapucu et al., "D-2 RECEPTOR IMAGING WITH IODINE-123-IODOBENZAMIDE BRAIN SPECT IN INFANTS WITH HYPOXIC-ISCHEMIC BRAIN INJURY", The Journal of nuclear medicine, 39(10), 1998, pp. 1703-1707
11. BECKER G; NAUMANN M; SCHEUBECK M; HOFMANN E; DEIMLING M; LINDNER A; GAHN G; REINERS C; TOYKA KV; REINERS K
    COMPARISON OF TRANSCRANIAL SONOGRAPHY, MAGNETIC-RESONANCE-IMAGING, AND SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY FINDINGS IN IDIOPATHIC SPASMODIC TORTICOLLIS
    Movement disorders
    
    G. Becker et al., "COMPARISON OF TRANSCRANIAL SONOGRAPHY, MAGNETIC-RESONANCE-IMAGING, AND SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY FINDINGS IN IDIOPATHIC SPASMODIC TORTICOLLIS", Movement disorders, 12(1), 1997, pp. 79-88
12. VALLABHAJOSULA S; HIRSCHOWITZ J; MACHAC J
    EFFECT OF HALOPERIDOL DOSE ON IODINE-123-IBZM BRAIN SPECT IMAGING IN SCHIZOPHRENIC-PATIENTS
    The Journal of nuclear medicine
    
    S. Vallabhajosula et al., "EFFECT OF HALOPERIDOL DOSE ON IODINE-123-IBZM BRAIN SPECT IMAGING IN SCHIZOPHRENIC-PATIENTS", The Journal of nuclear medicine, 38(2), 1997, pp. 203-207
13. LOBBEZOO F; SOUCY JP; HARTMAN NG; MONTPLAISIR JY; LAVIGNE GJ
    EFFECTS OF THE D2 RECEPTOR AGONIST BROMOCRIPTINE ON SLEEP BRUXISM - REPORT OF 2 SINGLE-PATIENT CLINICAL-TRIALS
    Journal of dental research
    
    F. Lobbezoo et al., "EFFECTS OF THE D2 RECEPTOR AGONIST BROMOCRIPTINE ON SLEEP BRUXISM - REPORT OF 2 SINGLE-PATIENT CLINICAL-TRIALS", Journal of dental research, 76(9), 1997, pp. 1610-1614
14. OLIVER DW; DORMEHL IC; VANDERSCHYF CJ; NEUMEYER JL; HUGO N; KEEVE R; ROSSOUW NT; MULLERGARTNER HW; CASTAGNOLI N
    EFFECT OF THE HALOPERIDOL TETRAHYDROPYRIDINE METABOLITE UOROPHENYL)-4-OXOBUTYL]-1,2,3,6-TETRAHYDROPYRIDINE ON DOPAMINE-RECEPTOR AND TRANSPORTER BINDING - A NONHUMAN PRIMATE I-123 IODOBENZAMIDE AND 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHIC STUDY
    Arzneimittel-Forschung
    
    D.W. Oliver et al., "EFFECT OF THE HALOPERIDOL TETRAHYDROPYRIDINE METABOLITE UOROPHENYL)-4-OXOBUTYL]-1,2,3,6-TETRAHYDROPYRIDINE ON DOPAMINE-RECEPTOR AND TRANSPORTER BINDING - A NONHUMAN PRIMATE I-123 IODOBENZAMIDE AND 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHIC STUDY", Arzneimittel-Forschung, 47(6), 1997, pp. 692-699
15. VANDERSCHYF CJ; DORMEHL IC; OLIVER DW; HUGO N; KEEVE R; MULLERGARTNER HW; POND SM; CASTAGNOLI N
    LONG-TERM TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG (HPTP) OF HALOPERIDOL INFLUENCES DOPAMINE LIGAND-BINDING IN BABOON BRAIN - AN [I-123] IODOBENZAMIDE (IBZM) SPECT STUDY
    Molecular brain research
    
    C.J. Vanderschyf et al., "LONG-TERM TREATMENT WITH THE TETRAHYDROPYRIDINE ANALOG (HPTP) OF HALOPERIDOL INFLUENCES DOPAMINE LIGAND-BINDING IN BABOON BRAIN - AN [I-123] IODOBENZAMIDE (IBZM) SPECT STUDY", Molecular brain research, 43(1-2), 1996, pp. 251-258
16. LOBBEZOO F; SOUCY JP; MONTPLAISIR JY; LAVIGNE GJ
    STRIATAL D2 RECEPTOR-BINDING IN SLEEP BRUXISM - A CONTROLLED-STUDY WITH IODINE-123-IODOBENZAMIDE AND SINGLE-PHOTON-EMISSION COMPUTED-TOMOGRAPHY
    Journal of dental research
    
    F. Lobbezoo et al., "STRIATAL D2 RECEPTOR-BINDING IN SLEEP BRUXISM - A CONTROLLED-STUDY WITH IODINE-123-IODOBENZAMIDE AND SINGLE-PHOTON-EMISSION COMPUTED-TOMOGRAPHY", Journal of dental research, 75(10), 1996, pp. 1804-1810
17. SCHLOSSER R; SCHLEGEL S
    D-2-RECEPTOR IMAGING WITH [I-123] IBZM AND SINGLE-PHOTON EMISSION TOMOGRAPHY IN PSYCHIATRY - A SURVEY OF CURRENT STATUS
    Journal of neural transmission
    
    R. Schlosser e S. Schlegel, "D-2-RECEPTOR IMAGING WITH [I-123] IBZM AND SINGLE-PHOTON EMISSION TOMOGRAPHY IN PSYCHIATRY - A SURVEY OF CURRENT STATUS", Journal of neural transmission, 99(1-3), 1995, pp. 173-185
18. LARUELLE M; ABIDARGHAM A; VANDYCK CH; ROSENBLATT W; ZEAPONCE Y; ZOGHBI SS; BALDWIN RM; CHARNEY DS; HOFFER PB; KUNG HF; INNIS RB
    SPECT IMAGING OF STRIATAL DOPAMINE RELEASE AFTER AMPHETAMINE CHALLENGE
    The Journal of nuclear medicine
    
    M. Laruelle et al., "SPECT IMAGING OF STRIATAL DOPAMINE RELEASE AFTER AMPHETAMINE CHALLENGE", The Journal of nuclear medicine, 36(7), 1995, pp. 1182-1190
19. KNABLE MB; JONES DW; COPPOLA R; HYDE TM; LEE KS; GOREY J; WEINBERGER DR
    LATERALIZED DIFFERENCES IN IODINE-123-IBZM UPTAKE IN THE BASAL GANGLIA IN ASYMMETRIC PARKINSONS-DISEASE
    The Journal of nuclear medicine
    
    M.B. Knable et al., "LATERALIZED DIFFERENCES IN IODINE-123-IBZM UPTAKE IN THE BASAL GANGLIA IN ASYMMETRIC PARKINSONS-DISEASE", The Journal of nuclear medicine, 36(7), 1995, pp. 1216-1225
20. LARUELLE M; VANDYCK C; ABIDARGHAM A; ZEAPONCE Y; ZOGHBI SS; CHARNEY DS; BALDWIN RM; HOFFER PB; KUNG HF; INNIS RB
    COMPARTMENTAL MODELING OF IODINE-123-IODOBENZOFURAN BINDING TO DOPAMINE D2 RECEPTORS IN HEALTHY-SUBJECTS
    The Journal of nuclear medicine
    
    M. Laruelle et al., "COMPARTMENTAL MODELING OF IODINE-123-IODOBENZOFURAN BINDING TO DOPAMINE D2 RECEPTORS IN HEALTHY-SUBJECTS", The Journal of nuclear medicine, 35(5), 1994, pp. 743-754
21. BERDING G; GRATZ KF; KOLBE H; MEYER GJ; DENGLER R; KNOOP BO; HUNDESHAGEN H
    I-123 IBZM SPECT - RECONSTRUCTION METHODOLOGY AND RESULTS IN PARKINSONISM AND DYSTONIA
    Nuklearmedizin
    
    G. Berding et al., "I-123 IBZM SPECT - RECONSTRUCTION METHODOLOGY AND RESULTS IN PARKINSONISM AND DYSTONIA", Nuklearmedizin, 33(5), 1994, pp. 194-199
22. NIKKINEN P; LIEWENDAHL K; SAVOLAINEN S; LAUNES J
    VALIDATION OF QUANTITATIVE BRAIN DOPAMINE-D2 RECEPTOR IMAGING WITH A CONVENTIONAL SINGLE-HEAD SPET CAMERA
    European journal of nuclear medicine
    
    P. Nikkinen et al., "VALIDATION OF QUANTITATIVE BRAIN DOPAMINE-D2 RECEPTOR IMAGING WITH A CONVENTIONAL SINGLE-HEAD SPET CAMERA", European journal of nuclear medicine, 20(8), 1993, pp. 680-683